
NCI-H358 [H-358, H358] - CRL-5807 - ATCC
NCI-H358 [H-358, H358] is an epithelial-like cell that was isolated from the bronchiole of a male patient with bronchioalveolar carcinoma. This cell line was deposited by AF Gazdar and JD Minna and can be used in cancer research.
Cellosaurus cell line NCI-H358 (CVCL_1559)
Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
Selective KRAS G12C inhibitors in non-small cell lung cancer ... - Nature
Nov 29, 2021 · A tool SHP2 inhibitor compound developed by Revolution Medicine is RMC-4550, which showed significant in vivo results when targeting KRAS G12C H358 and MIAPaCa-2 xenograft models both in terms of...
How to Culture & Edit NCI-H358 Cells: Best Practices for KRAS
Sep 5, 2024 · NCI-H358 is a human non-small cell lung cancer (NSCLC) cell line that is widely used in research related to KRAS gene mutations. The KRAS G12C mutation is relatively common in NSCLC and the NCI-H358 cell line harbors this mutation, which plays a critical role in tumor cell signaling and proliferation.
Acquired resistance to KRAS G12C small-molecule inhibitors
Oct 13, 2023 · We screened a panel of KRAS-G12C NSCLC cell lines and identified the ones that are inherently resistant or sensitive to sotorasib. We selected three cell lines, namely, H358, H23, and SW1573, based on their sensitivity to sotorasib in two-dimensional (2D) culture for further evaluation (Fig. 1A).
H358 non-small cell lung cancer tumor model - Hera BioLabs
H358 is a non-small cell lung cancer (NSCLC) cell line that harbors a KRAS mutation. KRAS mutations are found in >25% of lung adenocarcinomas leading to constitutive activation of the growth-promoting RAS signaling pathway. H358 cells were established from a chemotherapy-naïve NSCLC tumor.
Human genomic DNA (NCI-H358) - CRL-5807D - ATCC
High molecular weight genomic DNA isolated from the NCI-H358; human bronchioalveolar carcinoma; non-small cell lung cancer cell line.
NCI-H358 | Cell - PubChem
Jan 5, 2022 · Cell information for NCI-H358. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.
Cell Line: NCI-H358 - Laboratory Notes
Cell Line: NCI-H358, Established from primary bronchioalveolar carcinoma of the lung from a Caucasian male
Circular RNA circFGFR1 promotes progression and anti-PD-1 …
Dec 9, 2019 · NCI-H358 cancer cells with stably forced circFGFR1 expression were subcutaneously implanted into nude mice. Consistent with the above in vitro findings, the overexpression of circFGFR1 dramatically promoted tumor growth and lung metastasis (Fig. 2 …